SULFONAMIDTHIAZOLPYRIDINDERIVATE ALS ZUR BEHANDLUNG VON TYP-2-DIABETES GEEIGNETE GLUCOKINASEAKTIVATOREN

SULFONAMIDTHIAZOLPYRIDINDERIVATE ALS ZUR BEHANDLUNG VON TYP-2-DIABETES GEEIGNETE GLUCOKINASEAKTIVATOREN

The present invention provides compounds of the formula (I), which are activators of glucokinase activity and, thus, may be employed as therapeutic agents for the treatment of glucokinase mediated conditions. Accordingly, the compounds of formula (I) may be employed for the prevention and the treatm...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JAGTAP, VIKRANT, GUPTA, RAMESH, TULI, DAVINDER, MANDHARE, APPAJI, BEBERNITZ, GREGORY
Format: Patent
Sprache:ger
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention provides compounds of the formula (I), which are activators of glucokinase activity and, thus, may be employed as therapeutic agents for the treatment of glucokinase mediated conditions. Accordingly, the compounds of formula (I) may be employed for the prevention and the treatment of impaired glucose tolerance, Type 2 diabetes and obesity.